New approach for tuberculosis drugs

In the past 50 years, only one new tuberculosis drug has come on to the market, yet many more active substances are urgently needed. Current treatments increasingly fail due to multidrug-resistant pathogens. Researchers have now applied to patent a novel approach for developing new tuberculosis drugs.

Read the whole article on Science Daily

More from Science Daily